Table 9 Numerical details of the intermolecular interactions present in
5a
Table 11 Numerical details of the intermolecular interactions present in
6b
…
…
…
…
D A
˚
(A)
D–H
˚
(A)
H
A
D
A
Angle
(u)
D–H
˚
(A)
H
A
Angle
(u)
…
Donor (D)–H Acceptor (A)
…
Donor (D)–H Acceptor (A)
˚
(A)
˚
(A)
˚
(A)
a
a
…
…
…
…
N2A–H2NA O3A L[C10A]
0.86
0.93
0.96
0.96
2.06
2.43
2.36
2.65
2.805(13)
3.267(13)
3.221(17)
3.494(16)
144
113
148
150
N2G–H O3 L[C10]
0.88
0.99
0.98
0.98
2.07
2.65
2.39
2.77
2.801(1)
3.192(2)
3.352(3)
3.365(3)
139
115
166
120
c
a
…
C5A–H5A O1A L[C7A]
C1G–H2G O3 L[C10]
a
a
…
C8A–H8A O1A L[C7A]
C8–H82 O1 L[C7]
e
…
f
a
…
C16A–H16B O2B L[C9B]
C16–H16A O1 L[C7]
Equivalent position indicators:a 21 + x, y, z.
b
…
N2B–H2NB O3B L[C10B]
0.86
0.93
0.96
0.96
2.01
2.43
2.30
2.65
2.764(14)
3.270(15)
3.246(13)
3.519(15)
145
150
170
150
d
…
…
C5B–H5B O1B L[C7B]
b
C8B–H8B O1B L[C7B]
g
h
…
(d, J = 7.04 Hz, 1H, H5), 8.56 (s, 1H, H3), 10.84 (s, 1H, NHCO);
13C NMR (75.6 MHz, CDCl3): d 190.66, 169.10, 161.91 (3 6
CLO), 140.76 (ArC), 138.91 (ArCH), 136.40 (ArCH), 122.30
(ArCH), 120.29 (ArCH), 114.94 (ArC), 39.66 (NHCH2),
31.29, 29.09, 26.44, 22.43 (CH2(CH2)4CH3), 25.33 (COCH3),
13.91 (CH2(CH2)4CH3); HRMS (ESI) m/z calculated for
C16H21BrN2O3 (M + 1)+ 369.0736. Found 369.0791; Anal.
Calcd. for C16H21BrN2O3: C, 52.04; H, 5.73; N, 7.59. Found: C,
52.26; H, 5.94; N, 7.53%.
C16B–H16F O2A L[C9A]
Equivalent position indicators:a x, 21 + y, z. b x, 1 + y, z. c 2x, 2 2 y,
d
e
f
g
h
2z. 1 2 x, 2y, 2z. x, 1 + y, z. x, 2.5 2 y, K + z. x, y, z. x,
1 + y, z.
669, 648, 603, 561, 518 cm21 1H NMR (300 MHz, CDCl3):
;
d 0.90 (t, J = 6.84 Hz, 3H, CH2(CH2)4CH3), 1.29–1.44
(m, 6H, CH2CH2(CH2)3CH3), 1.56–1.66 (m, 2H, NHCH2CH2
(CH2)3CH3), 2.24 (s, 3H, COCH3), 3.38–3.45 (m, 2H,
NHCH2CH2(CH2)3CH3), 6.91 (s, 1H, CONH), 7.11–7.17 (m,
1H, H4), 7.59–7.65 (m, 1H, H5), 8.41 (dd, J = 1.51, 8,11 Hz, 1H,
H3), 8.67 (dd, J = 8.60, 0.88, Hz, 1H, H6), 10.96 (s, 1H, NHCO);
13C NMR (75.6 MHz, CDCl3): d 192.21, 169.19, 162.84 (3 6
CLO), 141.93 (ArC), 136.38 (ArCH), 134.30 (ArCH), 122.47
(ArCH), 120.57 (ArCH), 118.65 (ArC), 39.55 (NHCH2), 31.29,
29.14, 26.44, 22.43 (CH2(CH2)4CH3), 25.43 (COCH3), 13.90
(CH2(CH2)4CH3); HRMS (ESI) m/z calculated for C16H22N2O3
2-(2-Acetamidophenyl)-N-dodecyl-2-oxoacetamide, 5d.
N-Acetylglyoxylic amide 5d was prepared from 1-acetylindo-
line-2,3-dione (0.28 g, 1.5 mmol) and dodecylamine (0.28 g,
1.5 mmol) according to GP 1. The title compound 5d was
afforded as off-white flakes (0.41 g, 72%). The solid, recrystal-
lized from hexane via slow evaporation of the solvent at room
temperature, yielded crystals suitable for X-ray crystal structure
determination. 5d: mp 116–118 uC; UV (MeOH): lmax 207 nm (e
20 584 cm21M21), 233 (33 683), 266 (14 783), 333 (7547); IR
(KBr): nmax 3284, 3068, 2915, 2848, 1696, 1651, 1604, 1581, 1522,
1467, 1449, 1371, 1324, 1295, 1247, 1219, 1232, 1164, 1129, 1040,
(M
+
1)+ 291.1630. Found 291.1696; Anal. Calcd. for
C16H22N2O3: C, 66.18; H, 7.64; N, 9.65. Found: C, 66.29; H,
7.76; N, 9.59%.
1006, 892, 854, 813, 769, 721, 690, 628, 599, 552, 512 cm21; H
1
2-(2-Acetamido-5-bromophenyl)-N-hexyl-2-oxoacetamide, 5b.
The N-acetylglyoxylic amide 5b was prepared from 1-acetyl-5-
bromoindoline-2,3-dione (0.40 g, 1.5 mmol) and hexylamine
(0.15 g, 1.5 mmol). according to GP 1. The title compound 5b
was afforded as a light brown solid after purification by column
chromatography (0.61 g, 55%). The solid, recrystallized from
hexane or cyclohexane via slow evaporation of the solvent at
room temperature, yielded crystals suitable for X-ray crystal
structure determination. 5b: mp 116–118 uC; UV (MeOH): lmax
203 nm (e 31 023 cm21 M21), 238 (32 886), 345 (3000); IR (KBr):
nmax 3277, 2955, 2927, 2850, 1664, 1599, 1521, 1482, 1369, 1293,
1258, 1203, 1137, 822, 693 cm21; 1H NMR (300 MHz, CDCl3): d
0.91 (t, J = 6.76 Hz, 3H, CH2CH2(CH2)3CH3), 1.25–1.44 (m, 6H,
CH2CH2(CH2)3CH3), 1.56–1.66 (m, 2H, CH2CH2(CH2)3CH3),
2.21 (s, 3H, COCH3), 3.36–3.43 (m, 2H, NHCH2(CH2)4CH3),
6.95 (s, 1H, CONH), 7.66 (dd, J = 2.41, 9.08 Hz, 2H, H6), 8.53
NMR (300 MHz, CDCl3): d 0.87 (t, J = 6.65 Hz, 3H,
CH2CH2(CH2)9CH3), 1.25–1.39 (m, 18H, CH2CH2(CH2)9CH3),
1.56–1.66 (m, 2H, NHCH2CH2(CH2)9CH3), 2.21 (s, 3H,
COCH3), 3.36–3.43 (m, 2H, NHCH2(CH2)10CH3), 6.87 (s, 1H,
CONH), 7.14–7.09 (m, 1H, H4), 7.61–7.56 (m, 1H, H5), 8.35 (d,
J = 7.84 Hz, 1H, H3), 8.64 (d, J = 8.39 Hz, 1H, H6), 10.96 (s, 1H,
NHCO); 13C NMR (75.6 MHz, CDCl3): d 192.14, 169.16, 162.77
(3 6 CLO), 141.95 (ArC), 136.40 (ArCH), 134.32 (ArCH),
122.46 (ArCH), 120.59 (ArCH), 118.66 (ArC), 39.57 (NHCH2),
31.81, 29.54, 29.52, 29.47, 29.42, 29.24, 29.18, 29.13, 26.78, 22.59
(CH2(CH2)10CH3), 25.35 (COCH3), 14.02 (CH2(CH2)10CH3);
HRMS (ESI) m/z calculated for C22H34N2O3 (M + 1)+ 375.5170.
Found 375.2622; Anal. Calcd. for C22H34N2O3: C, 70.55; H,
9.15; N, 7.48. Found: C, 70.84; H, 9.21; N, 7.53%
Hexyl 2-(2-(2-acetamidophenyl)-2-oxoacetamido)acetate, 6b.
N-Acetyl glyoxylamide peptide mimic 6b was prepared from
1-acetylindoline-2,3-dione (0.37 g, 2 mmol) and glycine hexyl
ester hydrochloride (1 g, 5 mmol) according to GP 2. Purification
by gravity column chromatography over silica with CH2Cl2 gave
the title compound 6b as off-white flakes (0.31 g, 45%). The
solid, recrystallized from hexane via slow evaporation of the
solvent at room temperature, yielded crystals suitable for X-ray
crystal structure determination. 6b: mp 56–58 uC; UV (MeOH):
Table 10 Numerical details of the intermolecular interactions present in
5d
…
…
A
˚
(A)
D–H
˚
(A)
H
A
D
Angle
(u)
…
Donor (D)–H Acceptor (A)
˚
(A)
a
…
N2–H O3 L[C10]
0.86
0.97
0.93
0.96
2.04
2.70
2.46
2.50
b
2.788(6)
3.226(6)
3.278(6)
3.315(6)
144
115
147
133
a
…
C11–H11 O3 L[C10]
b
…
…
C5–H O1 L[C7]
b
C8–H O1 L[C7]
l
max 191 nm (e 30 116 cm21M21), 233 (29 362), 273 (12 824), 341
Equivalent position indicators:a x,21 + y, z. 1 2 x, 2 2 y, 1 2 z.
(6847); IR (KBr): nmax 3319, 2959, 2929, 2856, 1754, 1701, 1644,
7352 | CrystEngComm, 2012, 14, 7345–7354
This journal is ß The Royal Society of Chemistry 2012